Researchers in China successfully used CRISPR gene editing to produce five monkey clones from the fibroblasts of a donor monkey with disease phenotypes.
Study finds an association between resting state network connectivity abnormalities in those with major depressive disorder who experienced childhood trauma.
Anti-inflammatory medications, such as those commonly prescribed for arthritis, improve depressive symptoms in those with MDD.
Findings provide evidence to support the role of human roseoloviruses, HHV-6A, and HHV-6B in bipolar disorder and major depressive disorder.
Deep brain stimulation improves performance on cognitive control tasks and increases theta oscillations in the medial, and lateral prefrontal cortex.
Differences in serotonergic neuron morphology, along with altered gene expression have been identified in patients with MDD. The findings shed light on why some patients do not respond to SSRI antidepressants.
Transcranial alternating current brain stimulation (tACS) significantly reduced symptoms in people diagnosed with major depressive disorder in a pilot clinical trial.
Researchers shed new light on why some people may not respond to antidepressants for major depressive disorder. The study reports, neurons in the brains of some with MDD may become hyperactive in the presence of SSRIs.
A new study reports those with the highest genetic propensity to mental illness are twice as likely to be hospitalized for depression than those with the lowest propensity.
Researchers report 1 in 5 people are at risk of experiencing mental health conditions, such as PTSD or major depressive disorder, within 6 months of suffering mTBI.
Researchers have identified a significant overlap between suicide and major depressive disorder.
Researchers link social media factors to major depressive disorder in Millennials. The study found those with MDD were less likely to post photos of themselves with other people and reported having less social media followers.
